Eligibility Matcher
Select your organization type below to see only the grants you qualify for — sorted by soonest deadline.
403 grants for Special district governments
Sorted by deadline (soonest first)
Long-term health outcomes of people living with spina bifida
HHS-CDC-NCBDDD · CDC-RFA-DD-26-0222
BJA FY 2026 Veterans Treatment Court Program
USDOJ-OJP-BJA · O-BJA-2026-172714
BJA FY 2026 Prosecuting Cold Cases Using DNA
USDOJ-OJP-BJA · O-BJA-2026-172708
BJA FY 2026 DNA Capacity Enhancement for Backlog Reduction (CEBR)—Formula Grants Program
USDOJ-OJP-BJA · O-BJA-2026-172718
OJJDP FY 2026 Strengthening Internet Crimes Against Children (ICAC) Technological Investigative Capacity
USDOJ-OJP-OJJDP · O-OJJDP-2026-172753
OJJDP FY 2026 Multistate Mentoring Programs
USDOJ-OJP-OJJDP · O-OJJDP-2026-172745
BJA FY 2026 Paul Coverdell Forensic Science Improvement- Competitive Grants Program
USDOJ-OJP-BJA · O-BJA-2026-172711
GREGoRi Technology Integration Center (U01, Clinical Trials Optional)
HHS-NIH11 · RFA-HG-27-012
GREGoRi Innovation Projects (U01 Clinical Trial Optional)
HHS-NIH11 · RFA-HG-27-013
GREGoRi Data Coordination and Outreach Center (U01, Clinical Trials Not Allowed)
HHS-NIH11 · RFA-HG-27-011
BJA FY 2026 Rural Violent Crime Reduction Initiative
USDOJ-OJP-BJA · O-BJA-2026-172761
BJA FY 2026 Students, Teachers, and Officers Preventing (STOP) School Violence Program
USDOJ-OJP-BJA · O-BJA-2026-172709
HEAL Initiative: Whole Joint Health Program (R61/R33 Clinical Trial Required)
HHS-NIH11 · PAR-27-045
Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)
HHS-NIH11 · PAR-24-280
Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)
HHS-NIH11 · PAR-24-279
BJA FY 2026 Upholding the Rule of Law and Preventing Wrongful Convictions Program
USDOJ-OJP-BJA · O-BJA-2026-172726
BJA FY26 DNA Capacity Enhancement for Backlog Reduction (CEBR)—Competitive Grants Program
USDOJ-OJP-BJA · O-BJA-2026-172680
Exploring and Enhancing Outdoor and Heritage Tourism in the Chesapeake Bay Watershed
DOI-NPS · P27AS00032
Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)
HHS-NIH11 · PAR-25-255
Emerging Infections Network - Research for Preventing, Detecting, and Managing Travel-associated Infectious Diseases
HHS-CDC-HHSCDCERA · RFA-CK-26-035
US Travelers Health Research, Surveillance, Communication, and Outreach Network
HHS-CDC-HHSCDCERA · RFA-CK-26-036
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
HHS-NIH11 · PAR-25-095
Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
HHS-NIH11 · RFA-NS-26-001
Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
HHS-NIH11 · RFA-CA-27-002
Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
HHS-NIH11 · RFA-CA-27-001